{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-066317","form_type":"8-K","ticker":"EDIT","cik":"0001650664","company_name":"Editas Medicine, Inc.","filed_at":"2026-05-26T20:42:33+00:00","discovered_at":"2026-05-26T20:43:00.432578+00:00","generated_at":"2026-05-26T20:46:32.763929+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"confidence":"high","headline":"Editas Medicine prices $125M public offering of shares and warrants","bullets":["Priced 55,555,556 shares and warrants at $2.25 per unit; gross proceeds $125M before warrant exercise.","Warrants exercisable at $3.50/share, expire upon EDIT-401 Phase 1 data milestone or within 3 years.","If all warrants exercised, additional proceeds ~$194.4M; net proceeds estimated ~$117M.","Cash runway extended into second half of 2028 based on current plans.","Underwriters: Cantor Fitzgerald and Wells Fargo; closing expected May 27, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-066317","json":"https://secwatch.observer/filing/0001104659-26-066317.json","markdown":"https://secwatch.observer/filing/0001104659-26-066317.md","text":"https://secwatch.observer/filing/0001104659-26-066317.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1650664/000110465926066317/0001104659-26-066317-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1650664/000110465926066317/tm2615565d3_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T20:46:32.763929+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}